Advanced Proximal Colon-Oriented Delivery Technology
Delivering Innovation Beyond Conventional Drug Delivery
PROXYTECH™ is an innovative, multi-layered oral delivery technology under development, designed to protect sensitive active ingredients during gastrointestinal transit and promote their controlled release in the proximal colon.
Conventional oral formulations often release their active ingredients in the stomach or upper small intestine. For certain pharmaceutical, nutraceutical and microbiome-focused applications, these release characteristics may not be ideal.
PROXYTECH is being developed to address this challenge through an integrated approach combining microencapsulation, protective delivery matrices and controlled-release technologies, with the aim of improving site-specific delivery.
Our vision is to transform conventional oral formulations into advanced, scientifically designed delivery systems that offer greater control over where and when active ingredients become available.
The Science Behind PROXYTECH
A Multi-Layered Approach to Targeted Delivery
PROXYTECH is being designed around three complementary principles:
1. PROTECTION — Shielding Sensitive Active Ingredients
Advanced microencapsulation techniques are intended to help protect selected active ingredients against the challenging conditions encountered during gastrointestinal transit, including gastric acidity and digestive environments.
This approach is particularly relevant for acid-sensitive probiotics, bioactive compounds and other ingredients requiring protection before reaching their intended site of action.
2. TRANSIT — Delaying Premature Release
Protective matrices and appropriate delayed-release dosage-form technologies are being investigated to reduce premature liberation of active ingredients in the upper gastrointestinal tract.
Depending on formulation requirements, these may include specialized capsule shells, functional coatings and controlled-release multiparticulate systems.
3. TARGETED RELEASE — Harnessing the Colonic Environment
PROXYTECH explores the use of microbiota-responsive materials, including inulin-based delivery matrices, that may undergo degradation or fermentation in the colonic environment.
By integrating protective and microbiota-responsive mechanisms, the technology aims to promote the release of selected active ingredients in the proximal colon, subject to formulation-specific validation.
PROTECT → TRANSIT → RELEASE
Three principles. One advanced delivery concept.
Our Development Philosophy
Precision Through Formulation Science
At the heart of PROXYTECH is a commitment to research-driven formulation development.
Our technology-development programme focuses on:
- Ingredient and excipient compatibility
- Microencapsulation and protective-matrix optimization
- Gastrointestinal stability and release profiling
- Simulated gastric and intestinal conditions
- Microbiota-responsive release evaluation
- Dosage-form stability and manufacturability
- Product-specific validation of delivery performance
